XML 47 R28.htm IDEA: XBRL DOCUMENT v3.3.1.900
Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2015
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of stock-based Compensation Expense Allocation Within the Consolidated Statements of Income

Total stock-based compensation expense recognized was as follows:

 

 

For Years Ended December 31,

 

 

2015

 

 

2014

 

 

2013

 

COR

$

 

47

 

 

$

 

48

 

 

$

 

49

 

R&D

 

 

60

 

 

 

 

62

 

 

 

 

67

 

SG&A

 

 

169

 

 

 

 

156

 

 

 

 

160

 

Acquisition charges

 

 

10

 

 

 

 

11

 

 

 

 

11

 

Total

$

 

286

 

 

$

 

277

 

 

$

 

287

 

 

Schedule of Weighted Average Assumptions Used to Estimate the Fair Values for Non-qualified Stock Options

We estimate the fair values for non-qualified stock options using the Black-Scholes-Merton option-pricing model with the following weighted average assumptions.

 

 

For Years Ended December 31,

 

 

2015

 

 

2014

 

 

2013

 

Weighted average grant date fair value, per share

$

 

9.49

 

 

$

 

8.13

 

 

$

 

6.78

 

Weighted average assumptions used:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected volatility

 

 

22

%

 

 

 

22

%

 

 

 

26

%

Expected lives (in years)

 

 

7.3

 

 

 

 

7.3

 

 

 

 

7.4

 

Risk-free interest rates

 

 

1.64

%

 

 

 

2.45

%

 

 

 

1.43

%

Expected dividend yields

 

 

2.52

%

 

 

 

2.72

%

 

 

 

2.56

%

 

Schedule of Stock Option and RSU Transactions Under Long-term Incentive and Director Compensation Plans

Stock option and RSU transactions under our long-term incentive and director compensation plans during 2015 were as follows:

 

 

Stock Options

 

 

RSUs

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

Exercise Price

 

 

 

 

 

 

Grant Date Fair

 

 

Shares

 

 

per Share

 

 

Shares

 

 

Value per Share

 

Outstanding grants, December 31, 2014

 

57,647,446

 

 

$

 

32.84

 

 

 

17,303,815

 

 

$

 

35.24

 

Granted

 

11,913,832

 

 

 

 

53.95

 

 

 

2,679,437

 

 

 

 

53.22

 

Vested RSUs

 

 

 

 

 

 

 

 

(3,386,415

)

 

 

 

33.72

 

Forfeited and expired

 

(833,840

)

 

 

 

42.71

 

 

 

(541,295

)

 

 

 

36.94

 

Exercised

 

(11,953,455

)

 

 

 

31.33

 

 

 

 

 

 

 

 

Outstanding grants, December 31, 2015

 

56,773,983

 

 

 

 

37.45

 

 

 

16,055,542

 

 

 

 

38.51

 

 

Schedule of Shares Outstanding Under Stock Option Plans, by Exercise Price Range

Summarized information about stock options outstanding at December 31, 2015, is as follows:

 

 

 

 

Stock Options Outstanding

 

 

Options Exercisable

 

 

 

Number

 

 

Weighted Average

Weighted Average

 

 

Number

 

 

Weighted Average

 

Exercise Price

 

Outstanding

 

Remaining Contractual

Exercise Price

 

 

Exercisable

 

 

Exercise Price

 

Range

 

(Shares)

 

 

Life (Years)

per Share

 

 

(Shares)

 

 

per Share

 

$

14.47 to 20.00

 

 

3,499,029

 

 

 

3.1

 

 

$

 

14.96

 

 

 

3,499,029

 

 

$

 

14.96

 

 

20.01 to 30.00

 

 

8,385,885

 

 

 

3.1

 

 

 

 

25.56

 

 

 

8,377,295

 

 

 

 

25.56

 

 

30.01 to 40.00

 

 

21,215,903

 

 

 

6.0

 

 

 

 

33.00

 

 

 

12,732,409

 

 

 

 

33.21

 

 

40.01 to 50.00

 

 

12,012,519

 

 

 

8.1

 

 

 

 

44.11

 

 

 

2,229,828

 

 

 

 

44.10

 

 

50.01 to 58.98

 

 

11,660,647

 

 

 

9.1

 

 

 

 

53.96

 

 

 

1,521

 

 

 

 

55.41

 

 

14.47 to 58.98

 

 

56,773,983

 

 

 

6.5

 

 

 

 

37.45

 

 

 

26,840,082

 

 

 

 

29.35

 

 

Schedule of Stock Options That are Vested and Expected to Vest, Outstanding and Exercisable

Summarized information as of December 31, 2015, about outstanding stock options that are vested and expected to vest, as well as stock options that are currently exercisable, is as follows:

 

 

Outstanding Stock Options

 

 

 

 

 

(Fully Vested and

 

 

Options

 

 

Expected to Vest) (a)

 

 

Exercisable

 

Number of outstanding (shares)

 

 

55,421,103

 

 

 

 

26,840,082

 

Weighted average remaining contractual life (in years)

 

 

6.4

 

 

 

 

4.6

 

Weighted average exercise price per share

$

 

37.17

 

 

$

 

29.35

 

Intrinsic value (millions of dollars)

$

 

978

 

 

$

 

683

 

 

 

 

 

 

 

 

 

 

 

(a) Includes effects of expected forfeitures of approximately 1 million shares. Excluding the effects of expected forfeitures, the aggregate intrinsic value of stock options outstanding was $986 million.

 

 

Schedule of Director Deferred Compensation Payable in Shares

Director deferred stock activity during 2015 was as follows:

 

 

Director Deferred Stock (Shares)

 

Outstanding, December 31, 2014

 

135,722

 

New shares deferred

 

14,722

 

Issued

 

(7,531

)

Outstanding, December 31, 2015

 

142,913

 

 

Schedule of Employee Stock Purchase Plan Transactions

Employee stock purchase plan transactions during 2015 were as follows:

 

 

Employee Stock

 

 

 

 

 

Purchase Plan

 

 

 

 

 

(Shares)

 

 

Exercise Price

 

Outstanding grants, December 31, 2014

 

374,703

 

 

$

 

45.46

 

Granted

 

1,530,127

 

 

 

 

44.75

 

Exercised

 

(1,532,264

)

 

 

 

44.57

 

Outstanding grants, December 31, 2015

 

372,566

 

 

 

 

46.19

 

 

Schedule of Changes in Treasury Stock

The table below reflects the changes in our treasury shares:

 

 

Stock Options

 

 

RSUs

 

 

Treasury Shares

 

Balance, December 31, 2012

 

 

 

 

 

 

 

 

 

632,636,970

 

Repurchases

 

 

 

 

 

 

 

 

 

77,564,013

 

Shares used for:

 

 

 

 

 

 

 

 

 

 

 

Stock options/RSUs

 

(45,507,711

)

 

 

(5,741,981

)

 

 

 

 

Stock applied to taxes

 

 

 

 

1,461,422

 

 

 

 

 

ESPP

 

(2,386,834

)

 

 

 

 

 

 

 

Director deferred stock

 

 

 

 

 

 

 

(12,909

)

Total issued

 

(47,894,545

)

 

 

(4,280,559

)

 

 

(52,175,104

)

Balance, December 31, 2013

 

 

 

 

 

 

 

 

 

658,012,970

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases

 

 

 

 

 

 

 

 

 

61,665,209

 

Shares used for:

 

 

 

 

 

 

 

 

 

 

 

Stock options/RSUs

 

(19,503,382

)

 

 

(5,609,627

)

 

 

 

 

Stock applied to exercises or taxes

 

6,618

 

 

 

1,408,701

 

 

 

 

 

ESPP

 

(1,784,184

)

 

 

 

 

 

 

 

Director deferred stock

 

 

 

 

 

 

 

(7,178

)

Total issued

 

(21,280,948

)

 

 

(4,200,926

)

 

 

(25,481,874

)

Balance, December 31, 2014

 

 

 

 

 

 

 

 

 

694,189,127

 

 

 

 

 

 

 

 

 

 

 

 

 

Repurchases

 

 

 

 

 

 

 

 

 

51,384,339

 

Shares used for:

 

 

 

 

 

 

 

 

 

 

 

Stock options/RSUs

 

(11,953,455

)

 

 

(3,386,415

)

 

 

 

 

Stock applied to exercises or taxes

 

8,562

 

 

 

845,164

 

 

 

 

 

ESPP

 

(1,532,264

)

 

 

 

 

 

 

 

Director deferred stock

 

 

 

 

 

 

 

(7,531

)

Total issued

 

(13,477,157

)

 

 

(2,541,251

)

 

 

(16,018,408

)

Balance, December 31, 2015

 

 

 

 

 

 

 

 

 

729,547,527

 

 

Schedule of Shares Reserved for Issuance and Available for Future Grant

Shares available for future grants and reserved for issuance are summarized below:

 

 

 

December 31, 2015

 

 

 

Long-Term Incentive

 

 

 

 

 

 

 

 

 

 

 

and Director

 

 

Employee Stock

 

 

 

 

 

Shares

 

Compensation Plans

 

 

Purchase Plan

 

 

Total

 

Reserved for issuance (a)

 

 

105,793,583

 

 

 

38,032,774

 

 

 

143,826,357

 

Shares to be issued upon exercise of outstanding options and RSUs (a)

 

 

(72,972,438

)

 

 

(372,566

)

 

 

(73,345,004

)

Available for future grants

 

 

32,821,145

 

 

 

37,660,208

 

 

 

70,481,353

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Includes 142,913 shares credited to directors’ deferred stock accounts that settle in shares of TI common stock. These shares are not included as grants outstanding at December 31, 2015.

 

 

Schedule of Cash Proceeds Received from Share-based Payment Awards

The effects on cash flows were as follows:

 

 

For Years Ended December 31,

 

 

2015

 

 

2014

 

 

2013

 

Proceeds from common stock transactions

$

 

442

 

 

$

 

616

 

 

$

 

1,314

 

Tax benefit realized from stock options exercised

 

 

171

 

 

 

 

218

 

 

 

 

227